Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Respiratory tract

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    2,077 result(s) found for: Respiratory tract. Displaying page 1 of 104.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2005-000973-24 Sponsor Protocol Number: EK-NM-01-05 Start Date*: 2005-06-14
    Sponsor Name:ERREKAPPA EUROTERAPICI
    Full Title: Nimesulide spray in the treatment of simpthomatic inflammation with pain of the oral cavity (faringitis, stomatitis, pharyngitis) pre e post dental extraction. Randomised controlled vs active drug...
    Medical condition: DISEASES OF UPPER RESPIRATORY TRACT (GINGIVITIS; PHARYNGITIS; STOMATITIS)
    Disease: Version SOC Term Classification Code Term Level
    6.1 10062352 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-002980-17 Sponsor Protocol Number: BV-2005/01 PRIMES Start Date*: 2007-07-12
    Sponsor Name:OM PHARMA
    Full Title: Double-blind, placebo-controlled, randomised clinical study of Broncho-Vaxom® in children suffering from recurrent upper respiratory tract infections
    Medical condition: Recurrent upper respiratory tract infections in children
    Disease: Version SOC Term Classification Code Term Level
    9.1 10046306 Upper respiratory tract infection LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: HU (Completed) BE (Completed) CZ (Completed) AT (Completed) IT (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2016-002705-19 Sponsor Protocol Number: OMPeR Start Date*: Information not available in EudraCT
    Sponsor Name:FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
    Full Title: A phase IV, randomized, controlled, double-blind study on efficacy and safety of OM-85 in children with recurrent respiratory tract infections
    Medical condition: Recurrent Respiratory Tract Infection
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10039249 RTI LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-002733-22 Sponsor Protocol Number: MB0515/1021/03 Start Date*: 2015-09-09
    Sponsor Name:VALEAS SPA - INDUSTRIA CHIMICA E FARMACEUTICA
    Full Title: Combined treatment with pidotimod and bifidobacteria in pre-scholastic age children with recurrent respiratory infections: evaluation of clinical efficacy and parents' quality of life
    Medical condition: Recurrent respiratory infections
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10062352 Respiratory tract infection PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2010-021092-89 Sponsor Protocol Number: SICOG1001 Start Date*: 2011-04-07
    Sponsor Name:SOUTHERN ITALY COOPERATIVE ONCOLOGY GROUP
    Full Title: Cisplatin and Alimta with panitumumaB for Advanced non-squamous Lung cAncer (CABALA Trial): a SICOG multicenter, phase II trial
    Medical condition: previously untreated, EGFR + (FISH), advanced, non-squamous, NSCLC
    Disease: Version SOC Term Classification Code Term Level
    9.1 10029107 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-005740-83 Sponsor Protocol Number: 4825 Start Date*: 2007-01-12
    Sponsor Name:University of Southampton
    Full Title: A Pragmatic Randomised Trial of Ibuprofen, Paracetamol, Steam and Delayed Prescribing for Patients with Respiratory Tract Infections in Primary Care
    Medical condition: Inclusion criteria Patients aged 3 to 65 presenting to a GP or nurse with an RTI (acute cold, influenza, sore throat, otitis media, sinusitis, croup, or lower respiratory tract infection). Exclus...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10024970 Respiratory tract infections HLGT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2020-001675-33 Sponsor Protocol Number: VPM1002-DE-3.07CoV Start Date*: 2020-05-29
    Sponsor Name:Vakzine Projekt Management GmbH
    Full Title: A phase III, randomized, double-blind, placebo-controlled, multicentre, clinical trial to assess the efficacy and safety of VPM1002 in reducing hospital admissions and/or severe respiratory infecti...
    Medical condition: infectious respiratory diseases (e.g. COVID-19)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038738 - Respiratory, thoracic and mediastinal disorders 10024970 Respiratory tract infections HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-014301-14 Sponsor Protocol Number: 2009-014301-14 Start Date*: 2009-07-15
    Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI
    Full Title: Farmacologic prevention with Varenicline in heavy smokers undergoing early detection lung cancer screening
    Medical condition: Heavy smokers with higher risk in developing lung cancer and smoke related diseases
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038738 SOC
    9.1 10038716 HLGT
    9.1 10029107 HLGT
    9.1 10006334 HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-006435-13 Sponsor Protocol Number: 5065 Start Date*: 2008-10-15
    Sponsor Name:University of Southampton
    Full Title: GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).Workpackage 10: Antibiotic Trial One
    Medical condition: Lower Respiratory Tract Infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008477 Chest infection LLT
    9.1 10024968 Lower respiratory tract infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Completed)
    Trial results: View results
    EudraCT Number: 2007-002314-19 Sponsor Protocol Number: meduniwien_lma_lido_3 Start Date*: 2007-10-19
    Sponsor Name:Medical University of Vienna, Department of Anesthesiology
    Full Title: Larynxmaske bei Kindern nach Atemwegsinfekt: Der Effekt topischer Anästhesie mit Lidocain Effect of Lidocain-gel for laryngeal mask lubrification in pediatric patients after acute respiratory disease
    Medical condition: Acute respiratory diseases are common in pediatric patients scheduled for general anesthesia, and can cause perioperative problems up to 6 weeks after the acute respiratory infection. In the prese...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038700 Respiratory infection LLT
    Population Age: Children, Under 18 Gender: Male
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2009-010085-35 Sponsor Protocol Number: 6646 Start Date*: 2010-01-14
    Sponsor Name:Barts Health NHS Trust
    Full Title: Cluster-randomised, Double-Blind, Placebo-Controlled Trial of Vitamin D Supplementation for the Prevention of Influenza and other Respiratory Infections in Sheltered Accommodation (ViDiFlu)
    Medical condition: Trial in healthy volunteers; intended indication is for prevention of respiratory tract infections
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10062352 Respiratory tract infection PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2010-021422-35 Sponsor Protocol Number: 09-NI-EP-001 Start Date*: 2010-10-26
    Sponsor Name:Deutsche Homöopathie-Union, DHU-Arzneimittel GmbH & Co. KG
    Full Title: Efficacy, safety and tolerability of Influcid tablets in patients (1 to 65 years old) suffering from upper respiratory tract infections with flu-like symptoms. A randomized, international, multicen...
    Medical condition: Diagnosed upper respiratory tract infection (URTI) with presence of the following symptoms for equal or less than for 24 hours : a)Fever (axillary temperature >= 37.5°C) and b)At least one upper ...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10046734 URTI (upper respiratory tract infection) LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-000420-34 Sponsor Protocol Number: PRISTL06562 Start Date*: 2015-02-04
    Sponsor Name:sanofi-aventis France
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    18.0 10038738 - Respiratory, thoracic and mediastinal disorders 10024970 Respiratory tract infections HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2022-000886-42 Sponsor Protocol Number: BV-2020/08 Start Date*: 2022-09-06
    Sponsor Name:OM Pharma SA
    Full Title: A Randomised, Placebo-Controlled, 3-Arm, Double-Blind, Multicentre, Phase 4 Study to Assess the Efficacy of OM-85 (Broncho Vaxom) Short- and Long-Term Treatment vs. Placebo in the Prevention of Res...
    Medical condition: Respiratory Tract Infections with Wheezing Lower Respiratory Illness
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038738 - Respiratory, thoracic and mediastinal disorders 10024970 Respiratory tract infections HLGT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: HU (Trial now transitioned) PL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2007-003628-39 Sponsor Protocol Number: TNS0107 Start Date*: 2007-11-22
    Sponsor Name:ECUPHARMA S.R.L.
    Full Title: Pilot study to evaluate the local tollerability and efficacy of a new tobramycin 3% nasal spray formulation to reduce the bacterial density of Pseudomonas aeruginosa and/or Staphylococcus aureus, i...
    Medical condition: Rhinosinusal infection by Pseudomonas a. e/o Staphylococcus a. in patients with Cystic Fibrosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10024970 Respiratory tract infections HLGT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-001586-15 Sponsor Protocol Number: 5065 Start Date*: 2007-10-16
    Sponsor Name:University of Southampton
    Full Title: GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).Workpackage 10: Antibiotic Trial One
    Medical condition: Lower Respiratory Tract Infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008477 Chest infection LLT
    9.1 10024968 Lower respiratory tract infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) GB (Completed) BE (Completed) SE (Completed) ES (Completed) IT (Completed) DE (Completed) FR (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2007-001320-12 Sponsor Protocol Number: BAY 12-8039/12669 Start Date*: 2007-12-10
    Sponsor Name:BAYER
    Full Title: A national, prospective, randomized, open label study to asses the efficacy and safety of IV/PO moxifloxacin vs IV ceftriaxone + IV azithromicin followed by PO amoxicilline/clavulanate and PO clar...
    Medical condition: community-acquired pneumonia
    Disease: Version SOC Term Classification Code Term Level
    6.1 10024970 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-001760-31 Sponsor Protocol Number: J0022XST302 Start Date*: 2013-07-04
    Sponsor Name:PIERRE FABRE MEDICAMENT
    Full Title: Clinical efficacy and safety of J022X ST in the prevention of Recurrent Upper-Respiratory Tract Infections (RURTI) in children with a high risk of recurrence
    Medical condition: Recurrent Upper-Respiratory Tract Infections (RURTI)
    Disease: Version SOC Term Classification Code Term Level
    17.0 10021881 - Infections and infestations 10046306 Upper respiratory tract infection PT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed) LT (Completed) PL (Completed) RO (Completed)
    Trial results: View results
    EudraCT Number: 2007-002156-42 Sponsor Protocol Number: MB 1206/1770/04 Start Date*: 2007-11-22
    Sponsor Name:VALEAS
    Full Title: Effects of Treatment with Cefaclor in acute pharyngotonsillitis and activity on the immune system
    Medical condition: Acute pharyngotonsillitis
    Disease: Version SOC Term Classification Code Term Level
    6.1 10062352 PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2010-023227-26 Sponsor Protocol Number: Repha_1352 Start Date*: 2010-12-17
    Sponsor Name:Repha GmbH
    Full Title: Randomized, prospective double-blinded study to evaluate safety and efficacy of Angocin Anti-Infekt N versus placebo in the prophylaxis of respiratory tract infections
    Medical condition: Prophylaxis of respiratory tract infections
    Disease: Version SOC Term Classification Code Term Level
    12.1 10066740 Acute respiratory tract infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 23 18:02:37 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA